| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |